Skip to content

Escalon Medical Corp.: 10-Q filed 2020-05-14

What Escalon Medical Corp. reported in its quarterly report filed 2020-05-14 (fiscal Q3 2020): 39 published measures, 119 facts as tagged in accession 0000862668-20-000005.

This filing

Form
10-Q (quarterly report)
Filed
2020-05-14
Fiscal period
fiscal Q3 2020
Accession
0000862668-20-000005 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Escalon Medical Corp. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-03-315,552,950USD
At 2019-06-305,127,438USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-03-313,572,564USD
At 2019-06-302,965,199USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-03-311,980,386USD
At 2019-12-312,108,269USD
At 2019-09-302,783,612USD
At 2019-06-302,162,239USD
At 2019-03-312,168,741USD
At 2018-12-312,146,536USD
At 2018-09-302,364,519USD
At 2018-06-302,412,255USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-03-31695,648USD
At 2019-06-30409,743USD
At 2019-03-31528,280USD
At 2018-06-30874,002USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-01-01 to 2020-03-31-127,883USD91
2019-07-01 to 2020-03-31-181,853USD275
2019-10-01 to 2019-12-31-675,343USD92
2019-07-01 to 2019-09-30621,373USD92
2019-01-01 to 2019-03-3122,205USD90
2018-07-01 to 2019-03-31-243,514USD274
2018-10-01 to 2018-12-31-217,983USD92
2018-07-01 to 2018-09-30-47,736USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-07-01 to 2020-03-31329,355USD275
2018-07-01 to 2019-03-31-371,357USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2020-01-01 to 2020-03-312,357,383USD91
2019-07-01 to 2020-03-317,385,264USD275
2019-01-01 to 2019-03-312,668,670USD90
2018-07-01 to 2019-03-317,345,933USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-07-01 to 2020-03-31-2,522USD275
2018-07-01 to 2019-03-3134,489USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-07-01 to 2020-03-31-38,971USD275
2018-07-01 to 2019-03-31-6,506USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-03-31-68,374,072USD
At 2019-06-30-68,192,219USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2020-01-01 to 2020-03-317,415,329shares91
2019-07-01 to 2020-03-317,415,329shares275
2019-01-01 to 2019-03-317,415,329shares90
2018-07-01 to 2019-03-317,415,329shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2020-01-01 to 2020-03-317,415,329shares91
2019-07-01 to 2020-03-317,415,329shares275
2019-01-01 to 2019-03-3112,017,856shares90
2018-07-01 to 2019-03-317,415,329shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2020-01-01 to 2020-03-31-0.02USD/shares91
2019-07-01 to 2020-03-31-0.03USD/shares275
2019-01-01 to 2019-03-310USD/shares90
2018-07-01 to 2019-03-31-0.04USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2020-01-01 to 2020-03-31-0.02USD/shares91
2019-07-01 to 2020-03-31-0.03USD/shares275
2019-01-01 to 2019-03-310USD/shares90
2018-07-01 to 2019-03-31-0.04USD/shares274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-03-3184,399USD
At 2019-06-3067,896USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-03-31-128,307USD91
2019-07-01 to 2020-03-31-935,035USD275
2019-01-01 to 2019-03-3122,185USD90
2018-07-01 to 2019-03-31-247,757USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-03-314,099,563USD
At 2019-06-304,260,921USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2020-01-01 to 2020-03-311,718USD91
2019-07-01 to 2020-03-319,821USD275
2019-01-01 to 2019-03-313,995USD90
2018-07-01 to 2019-03-3114,268USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-03-312,597,099USD
At 2019-06-302,260,209USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-03-31680,531USD
At 2019-06-30666,510USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2020-03-31126,962USD
At 2019-06-30141,700USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-03-311,114,037USD
At 2019-06-301,496,105USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2020-03-311,900,268USD
At 2019-06-301,878,860USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2020-01-01 to 2020-03-31903,666USD91
2019-07-01 to 2020-03-312,997,023USD275
2019-01-01 to 2019-03-311,030,778USD90
2018-07-01 to 2019-03-313,171,931USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-01-01 to 2020-03-31301,029USD91
2019-07-01 to 2020-03-31808,426USD275
2019-01-01 to 2019-03-31218,014USD90
2018-07-01 to 2019-03-31540,760USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-03-317,415,329shares
At 2019-06-307,415,329shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2020-03-31950,740USD
At 2019-06-30662,878USD
At 2018-12-31780,628USD
At 2018-06-301,124,002USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-03-3169,702,043USD
At 2019-06-3069,702,043USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2020-03-311,179,240USD
At 2019-09-301,179,240USD
At 2019-07-011,137,878USD
At 2019-06-300USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2019-07-011,208,000USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2020-03-31683,409USD
At 2019-06-30656,707USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2020-01-01 to 2020-03-31-140,889USD91
2019-07-01 to 2020-03-31-220,871USD275
2019-01-01 to 2019-03-319,482USD90
2018-07-01 to 2019-03-31-282,249USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2019-07-01 to 2020-03-3137,206USD275
2018-07-01 to 2019-03-3120,381USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2020-01-01 to 2020-03-311,350USD91
2019-07-01 to 2020-03-31759,371USD275
2019-01-01 to 2019-03-310USD90
2018-07-01 to 2019-03-3111,122USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-01-01 to 2020-03-31424USD91
2019-07-01 to 2020-03-31753,182USD275
2019-01-01 to 2019-03-3120USD90
2018-07-01 to 2019-03-314,243USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2019-07-01 to 2020-03-3112,515USD275
2018-07-01 to 2019-03-3142,242USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2019-07-01 to 2020-03-31-382,068USD275
2018-07-01 to 2019-03-31235,784USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-07-01 to 2020-03-3121,408USD275
2018-07-01 to 2019-03-31-138,430USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2019-07-01 to 2020-03-3114,021USD275
2018-07-01 to 2019-03-31146,232USD274

Inspect the source

Entity
Escalon Medical Corp. / CIK 0000862668
Captured
2026-09-20T04:59:43.148Z
SEC response SHA-256
1553c3790334a15d4c4528d0e1ce16eac37d12130ed9cd66f6b338c07ce2533d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000862668.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))